
Ask a doctor about a prescription for Abiraterone Sinthon
Abiraterone acetate
Abiraterone Synthon contains the active substance abiraterone acetate. It is used in adult men to treat prostate cancer that has spread to other parts of the body. Abiraterone Synthon works by stopping the production of testosterone in the body; this can slow down the growth of prostate cancer.
When Abiraterone Synthon is used at an early stage of the disease in patients who are responding to hormone therapy, it is given together with a treatment that lowers testosterone levels (androgen deprivation therapy).
During treatment with this medicine, your doctor will also prescribe another medicine called prednisone or prednisolone. This is to reduce the risk of high blood pressure, fluid retention (oedema), or low potassium levels in the blood.
Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Abiraterone Synthon.
Before taking this medicine, discuss with your doctor or pharmacist:
Tell your doctor if you have any heart or blood vessel problems, including abnormal heart rhythms (arrhythmia), or if you are taking medicines for these conditions.
Tell your doctor if you have yellowing of the skin or eyes, dark urine, severe nausea or vomiting, which can be signs of liver problems. Rarely, acute liver failure can occur, which can be life-threatening.
There may be a decrease in red blood cells, decreased sex drive, muscle weakness, and/or muscle pain.
Abiraterone Synthon must not be taken in combination with Ra-223 due to the possible increased risk of bone fractures or death.
If you plan to take Ra-223 after treatment with Abiraterone Synthon and prednisone/prednisolone, you should wait 5 days before starting Ra-223 treatment.
If you are unsure whether any of the above applies to you, talk to your doctor or pharmacist before taking Abiraterone Synthon.
Abiraterone Synthon may affect your liver and you may not have any symptoms. While taking this medicine, your doctor will periodically do blood tests to check how the medicine is affecting your liver.
This medicine is not for use in children and adolescents. If Abiraterone Synthon is accidentally swallowed by a child, seek medical advice immediately and take the package leaflet with you to show to the doctor.
Before taking any medicine, consult your doctor or pharmacist.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, and about any medicines you plan to take. This is important because Abiraterone Synthon can increase the effects of many medicines, including heart medicines, sedatives, certain anti-diabetic medicines, herbal medicines (such as St. John's Wort), and others. Your doctor may need to adjust the dose of these medicines.
Also, other medicines may increase or decrease the effects of Abiraterone Synthon. This can lead to side effects or Abiraterone Synthon not working properly.
Androgen deprivation therapy may increase the risk of abnormal heart rhythms. Tell your doctor if you are taking medicines for:
Tell your doctor if you are taking any of the above medicines.
Abiraterone Synthon is not for use in women.
It is unlikely that this medicine will affect your ability to drive or use machines.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
The medicine contains 24 mg of sodium (a major component of cooking salt) in each dose of two 500 mg tablets. This is approximately 1% of the maximum recommended daily intake of sodium for adults.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
The recommended dose is 1000 mg (two 500 mg tablets) taken once a day.
Your doctor may also prescribe other medicines for you to take with Abiraterone Synthon and prednisone or prednisolone.
If you take more Abiraterone Synthon than you should, talk to a doctor or go to a hospital immediately.
Do not stop taking Abiraterone Synthon or prednisone or prednisolone without talking to your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very Common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Frequency Not Known(cannot be estimated from the available data):
Bone loss (osteoporosis) may occur in men treated for prostate cancer. Abiraterone Synthon in combination with prednisone and prednisolone may make this worse.
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via the national reporting system listed in the [insert national agency] Adverse Reaction Reporting Scheme, [insert contact details]. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister, bottle, or carton after "EXP" and "Expiry Date". The expiry date refers to the last day of that month.
There are no special storage instructions for this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Oval, film-coated tablets, purple in color, approximately 19 mm in length and 11 mm in width, with "A7TN" engraved on one side and "500" on the other.
Pack sizes:
Synthon B.V.
Microweg 22
6545 CM Nijmegen
Netherlands
Synthon Hispania S.L.
Castelló 1
08830 Sant Boi de Llobregat
Barcelona
Spain
Synthon B.V.
Microweg 22
6545 CM Nijmegen
Netherlands
Date of Last Revision: 21/08/2024
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Abiraterone Sinthon – subject to medical assessment and local rules.